Results 91 to 100 of about 624,915 (310)

Dual PI3K/AKT and CDK4/6 inhibition reveals selective sensitivity in an SHH medulloblastoma stem cell model

Molecular Oncology, EarlyView.
Targeted therapy was evaluated in SHH medulloblastoma using neuroepithelial stem cell (NES) and tumor‐derived NES‐like (tNES) models in 2D monolayers and 3D spheroids. PI3K, AKT, and CDK4/6 inhibitors had minimal effects in NES but markedly reduced viability and growth and induced apoptosis in tNES cells, revealing distinct therapeutic vulnerabilities.
Monika Lukoseviciute, Madeleine Birgersson, Paolo Ceriani, Margareta Wilhelm, Ourania N Kostopoulou   +4 more
wiley   +1 more source

Multiple organ failure in the newborn: the point of view of the pathologist

Journal of Pediatric and Neonatal Individualized Medicine, 2014
One of the most severe events occurring in critically ill patients admitted to a neonatal intensive care unit (NICU) center is represented by the multiple organ failure (MOF), a systemic inflammatory response leading to a progressive organ dysfunction ...
Clara Gerosa, Eleonora Obinu, Daniela Fanni, Rossano Ambu, Gavino Faa   +4 more
doaj   +1 more source

Recommendations for processing cardiovascular surgical pathology specimens: a consensus statement from the Standards and Definitions Committee of the Society for Cardiovascular Pathology and the Association for European Cardiovascular Pathology.

, 2012
With the advent of molecular subclassification of diseases, much consideration should be given to the proper processing of cardiovascular surgical pathology specimens to maximize patient care.
Radio SJ, Tan CD, Tan, Carmela D., Padera RF, Baandrup, Ulrik, Veinot, John P., Kim Suvarna, THIENE, GAETANO, Mary N. Sheppard, Gaetano Thiene, Allard C. van der Wal, Miller DV, Carmela D. Tan, van der Wal AC, Sheppard, Mary N., Radio, Stanley J., John P. Veinot, van der Wal, Allard C., Bruneval P, Baandrup, Ulrik T., Dylan V. Miller, Butany J, Stone, James R., Miller, Dylan V., Gallagher, Patrick J., Veinot JP, Butany, Jagdish, Marc K. Halushka, Robert F. Padera, Padera, Robert F., BASSO, CRISTINA, Sheppard MN, Bruneval, Patrick, Cristina Basso, Halushka, Marc K., James R. Stone, Halushka MK, Stanley J. Radio, Gallagher PJ, Patrick J. Gallagher, Patrick Bruneval, Ulrik T. Baandrup, Jagdish Butany, Suvarna, Kim, Stone JR, Suvarna K, Baandrup UT   +46 more
core   +1 more source

Establishment of a humanized patient‐derived xenograft mouse model of high‐grade serous ovarian cancer for preclinical evaluation of combination immunotherapy

Molecular Oncology, EarlyView.
We have established a humanized orthotopic patient‐derived xenograft (Hu‐oPDX) mouse model of high‐grade serous ovarian cancer (HGSOC) that recapitulates human tumor–immune interactions. Using combined anti‐PD‐L1/anti‐CD73 immunotherapy, we demonstrate the model's improved biological relevance and enhanced translational value for preclinical ...
Luka Tandaric, Line Bjørge, Martine Rott Lode, Cecilie Fredvik Torkildsen, Pia Aehnlich, Rammah Elnour, Daniela Elena Costea, Lars Andreas Akslen, Liv Cecilie Vestrheim Thomsen, Emmet McCormack, Katrin Kleinmanns   +10 more
wiley   +1 more source

Deciphering transcriptional plasticity in pancreatic ductal adenocarcinoma reveals alterations in sensory neuron innervation

Molecular Oncology, EarlyView.
Pancreatic sensory neurons innervating healthy and PDAC tissue were retrogradely labeled and profiled by single‐cell RNA sequencing. Tumor‐associated innervation showed a dominant neurofilament‐positive subtype, altered mitochondrial gene signatures, and reduced non‐peptidergic neurons.
Elena Genova, Michele Montrone, Uday Rangaswamy, Francesco Diversi, Irene Schiavo, Denise Ferrarini, Roberta Di Florio, Irene Longo, Michele Coscia, Nicola Zamboni, Giorgia Demontis, Lisa Veghini, Vincenzo Corbo, Remo Sanges, Paul Heppenstall   +14 more
wiley   +1 more source

p53 suppresses type II endometrial carcinomas in mice and governs endometrial tumour aggressiveness in humans

EMBO Molecular Medicine, 2012
Type II endometrial carcinomas are a highly aggressive group of tumour subtypes that are frequently associated with inactivation of the TP53 tumour suppressor gene.
Peter J. Wild, Kristian Ikenberg, Thomas J. Fuchs, Markus Rechsteiner, Strahil Georgiev, Niklaus Fankhauser, Aurelia Noske, Matthias Roessle, Rosmarie Caduff, Athanassios Dellas, Daniel Fink, Holger Moch, Wilhelm Krek, Ian J. Frew   +13 more
doaj   +1 more source

Personal Papers (MS 80-0002)

, 1955
Letter from A. H. Blackshear, Jr., to Surgical Pathology enclosing a check for $10.00 covering he statement of July 27, 1955 for the account of Mrs.
Blackshear, A. H., Jr.
core  

Modern surgical pathology

, 2009
Online and in print, Modern Surgical Pathology, 2nd Edition presents today's most complete, current, and practical assistance in evaluating and signing out surgical specimens. Nearly 3,000 high-quality color pathology images provide a crystal-clear basis
Cote, Richard J, Weidner, Noel, Weiss, Lawrence M, Suster, Saul   +3 more
core   +1 more source

CCDC80 suppresses high‐grade serous ovarian cancer migration via negative regulation of B7‐H3

Molecular Oncology, EarlyView.
PAX8 is a lineage‐specific master regulator of transcription in high‐grade serous ovarian cancer (HGSC) progression. We show for the first time that PAX8 facilitates proliferation and metastasis by repressing the cell autonomous tumor suppressor CCDC80 and inducing B7‐H3 expression.
Aya Saleh, Nitzan Medina‐Itzhaki, Milena Chekov, Eden Gal‐Swisa, Roba Gabesh‐Wahabi, Inbar Savyon, Inna Naroditsky, Hilary A. Kenny, Basem Fares, Lina Korsensky, Einav Girsh, Liron Berger, Ruth Perets   +12 more
wiley   +1 more source

Surgical pathology of Hirschsprung disease (HSCR)

World Journal of Pediatric Surgery
The practice, art and science of surgical pathology for disease entities evolves continuously. Standards for diagnosis and management of Hirschsprung disease (HSCR), variants and related dysmotility disorders are no exception. Morphologic parameters that
Raquel González, Hector L Monforte, Michael Wilsey   +2 more
doaj   +1 more source